Hepatitis B: TherVacB Vaccine Study

We are testing a new vaccine for adults with hepatitis B to see if it is safe and how well it boosts the immune response. The study will also check if it helps reduce the virus in the body.

6-12 months16-20 visitsSafety phase (I)Efficacy phase (II)No PlaceboInvestigational MedicinesInjectionHepatologyInfectious Diseases

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Hbvaxpro
Hbvaxpro is a vaccine used to protect people against hepatitis B infection.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Aluminium
Aluminium is a metal often used in compounds to neutralize stomach acid or act as an immune-response enhancer in vaccines.
Hepatitis B Surface Antigen (Rdna)
Hepatitis B surface antigen (rDNA) stimulates the immune system to produce protection against hepatitis B infection.
Hepatitis B Surface Antigen (Rdna) [produced In S. Cerevisiae Cells By Rdna]
Hepatitis B surface antigen (recombinant) is a substance that stimulates the immune system to help prevent hepatitis B infection.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Mosaic Hbcoreag

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Goethe University Frankfurt
Universitätsmedizin Frankfurt, Studienzentrale der Med. Klinik 1
Frankfurt am Main, Germany
University Medical Center Hamburg-Eppendorf
Zentrum für Innere Medizin, I. Medizinische Klinik und Poliklinik
Hamburg, Germany
Medizinische Hochschule Hannover
Klinik für Gastroenterologie, Hepatologie, Infektiologie und Endokrinologie
Laatzen, Germany
Sponsor: Klinikum der Universitaet Muenchen AöR
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.